Amanote Research
Register
Sign In
Access to Hepatitis C Treatment for Patients in Drug Substitution Programmes: The Fight Is Far From Over
Swiss Medical Weekly
- Switzerland
doi 10.4414/smw.2017.14570
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Date
December 11, 2017
Authors
Unknown
Publisher
EMH Swiss Medical Publishers, Ltd.
Related search
Is Response to Anti–hepatitis C Virus Treatment Predictive of Mortality in Hepatitis C Virus/HIV-positive Patients?
AIDS
Infectious Diseases
Allergy
Immunology
Drug Treatment Clients' Readiness for Hepatitis C Treatment: Implications for Expanding Treatment Services in Drug and Alcohol Settings
Australian Health Review
Health Policy
When Enough Is Not Enough: Screening, Brief Intervention and Referral to Treatment for Hepatitis C in Patients Presenting to the Emergency Department
Academic Emergency Medicine
Medicine
Emergency Medicine
Viral Determinants of Resistance to Treatment in Patients With Hepatitis C
Clinical Microbiology Reviews
Immunology
Environmental
Public Health
Microbiology
Microbiology
Epidemiology
Infectious Diseases
Occupational Health
Barriers to Hepatitis C Treatment
Liver International
Hepatology
PH Professional Network: Drug-Drug Interactions: Treatment Considerations for Pulmonary Hypertension Patients With Human Immunodeficiency Virus and/or Hepatitis C
Advances in Pulmonary Hypertension
Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients
PLoS ONE
Multidisciplinary
Access to Treatment for Hepatitis B Virus Infection-Worldwide, 2016
American Journal of Transplantation
Transplantation
Allergy
Immunology
Pharmacology
Transforming Treatment for Hepatitis C
The Lancet
Medicine
